)
Biogen Pharmachem Industries (531752) investor relations material
Biogen Pharmachem Industries Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Board approved unaudited financial results for the quarter and nine months ended December 31, 2025.
Significant events and developments
Board meeting held on February 11, 2026, to consider and approve financial results.
Risk factors and uncertainties
Independent auditor's review found no material misstatements or non-compliance in the financial statements.
- Q2 FY26 saw a sharp revenue drop, net loss, and higher equity, with strong cash flows.531752
Q2 25/2610 Nov 2025 - Revenue and net profit rebounded sharply year-over-year, with EPS turning positive.531752
Q1 25/2628 Jul 2025 - Q2 FY25 saw Biogen Pharmachem swing to a net loss with declining income and equity.531752
Q2 24/2513 Jun 2025 - Q1 FY25 revenue turned negative and net loss reached ₹15.83 lakhs, reversing prior gains.531752
Q1 24/2513 Jun 2025 - Q3 FY25 saw a net loss and major board changes at Biogen Pharmachem Industries.531752
Q3 24/256 Jun 2025 - FY25 saw Biogen Pharmachem return to profit with robust revenue growth and capital inflow.531752
Q4 24/256 Jun 2025
Next Biogen Pharmachem Industries earnings date
Next Biogen Pharmachem Industries earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)